134 related articles for article (PubMed ID: 22236057)
1. Plasma-derived human antithrombin attenuates ventilator-induced coagulopathy but not inflammation in a Streptococcus pneumoniae pneumonia model in rats.
Aslami H; Haitsma JJ; Hofstra JJ; Florquin S; Dos Santos C; Streutker C; Zhang H; Levi M; Slutsky AS; Schultz MJ
J Thromb Haemost; 2012 Mar; 10(3):399-410. PubMed ID: 22236057
[TBL] [Abstract][Full Text] [Related]
2. Plasma-derived human C1-esterase inhibitor does not prevent mechanical ventilation-induced pulmonary complement activation in a rat model of Streptococcus pneumoniae pneumonia.
de Beer FM; Aslami H; Hoeksma J; van Mierlo G; Wouters D; Zeerleder S; Roelofs JJ; Juffermans NP; Schultz MJ; Lagrand WK
Cell Biochem Biophys; 2014 Nov; 70(2):795-803. PubMed ID: 24760631
[TBL] [Abstract][Full Text] [Related]
3. Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia.
Haitsma JJ; Schultz MJ; Hofstra JJ; Kuiper JW; Juco J; Vaschetto R; Levi M; Zhang H; Slutsky AS
Eur Respir J; 2008 Dec; 32(6):1599-606. PubMed ID: 18768578
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats.
Choi G; Hofstra JJ; Roelofs JJ; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; van der Poll T; Levi M; Schultz MJ
Crit Care Med; 2008 Jan; 36(1):204-10. PubMed ID: 18090375
[TBL] [Abstract][Full Text] [Related]
5. Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats.
Hofstra JJ; Cornet AD; de Rooy BF; Vlaar AP; van der Poll T; Levi M; Zaat SA; Schultz MJ
Crit Care; 2009; 13(5):R145. PubMed ID: 19740417
[TBL] [Abstract][Full Text] [Related]
6. Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury.
Chimenti L; Camprubí-Rimblas M; Guillamat-Prats R; Gomez MN; Tijero J; Blanch L; Artigas A
Thromb Haemost; 2017 Nov; 117(11):2125-2134. PubMed ID: 29202212
[No Abstract] [Full Text] [Related]
7. Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia.
van den Boogaard FE; Hofstra JJ; van 't Veer C; Levi MM; Roelofs JJ; van der Poll T; Schultz MJ
PLoS One; 2015; 10(5):e0127261. PubMed ID: 25992779
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated protein C attenuates coagulopathy and inflammation when administered early in murine pneumococcal pneumonia.
Schouten M; van 't Veer C; Roelofs JJ; Gerlitz B; Grinnell BW; Levi M; van der Poll T
Thromb Haemost; 2011 Dec; 106(6):1189-96. PubMed ID: 21901240
[TBL] [Abstract][Full Text] [Related]
9. Nebulized Recombinant Human Tissue Factor Pathway Inhibitor Attenuates Coagulation and Exerts Modest Anti-inflammatory Effects in Rat Models of Lung Injury.
van den Boogaard FE; Hofstra JJ; Brands X; Levi MM; Roelofs JJ; Zaat SA; Van't Veer C; van der Poll T; Schultz MJ
J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):91-99. PubMed ID: 27977318
[TBL] [Abstract][Full Text] [Related]
10. Nebulized anticoagulants limit pulmonary coagulopathy, but not inflammation, in a model of experimental lung injury.
Hofstra JJ; Vlaar AP; Cornet AD; Dixon B; Roelofs JJ; Choi G; van der Poll T; Levi M; Schultz MJ
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23(2):105-11. PubMed ID: 20073557
[TBL] [Abstract][Full Text] [Related]
11. Effects of activated protein C on ventilator-induced lung injury in rats.
Jiang JS; Chou HC; Wang LF; Lang YD; Chen CM
Respiration; 2010; 80(3):246-53. PubMed ID: 20110652
[TBL] [Abstract][Full Text] [Related]
12. Nebulized anticoagulants limit coagulopathy but not inflammation in pseudomonas aeruginosa-induced pneumonia in rats.
Cornet AD; Hofstra JJ; Vlaar AP; van den Boogaard FE; Roelofs JJ; van der Poll T; Levi M; Groeneveld AB; Schultz MJ
Shock; 2011 Oct; 36(4):417-23. PubMed ID: 21897338
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia.
Van Den Boogaard FE; Brands X; Schultz MJ; Levi M; Roelofs JJ; Van 't Veer C; Van Der Poll T
J Thromb Haemost; 2011 Jan; 9(1):122-32. PubMed ID: 21029363
[TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome.
Glas GJ; Van Der Sluijs KF; Schultz MJ; Hofstra JJ; Van Der Poll T; Levi M
J Thromb Haemost; 2013 Jan; 11(1):17-25. PubMed ID: 23114008
[TBL] [Abstract][Full Text] [Related]
15. Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation.
Choi G; Vlaar AP; Schouten M; Van't Veer C; van der Poll T; Levi M; Schultz MJ
Eur Respir J; 2007 Sep; 30(3):423-8. PubMed ID: 17537762
[TBL] [Abstract][Full Text] [Related]
16. Variable ventilation enhances ventilation without exacerbating injury in preterm lambs with respiratory distress syndrome.
Berry CA; Suki B; Polglase GR; Pillow JJ
Pediatr Res; 2012 Oct; 72(4):384-92. PubMed ID: 22805999
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary activation of coagulation and inhibition of fibrinolysis after burn injuries and inhalation trauma.
Hofstra JJ; Vlaar AP; Knape P; Mackie DP; Determann RM; Choi G; van der Poll T; Levi M; Schultz MJ
J Trauma; 2011 Jun; 70(6):1389-97. PubMed ID: 21460745
[TBL] [Abstract][Full Text] [Related]
18. Physiologic and biologic characteristics of three experimental models of acute lung injury in rats.
Henzler D; Hochhausen N; Chankalal R; Xu Z; Whynot SC; Slutsky AS; Zhang H
Anesth Analg; 2011 May; 112(5):1139-46. PubMed ID: 21474656
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of inflammatory mediators and function: experimental lung injury in nonpulmonary sepsis.
Uematsu S; Engelberts D; Peltekova V; Otulakowski G; Post M; Kavanagh BP
Crit Care Med; 2013 Jan; 41(1):151-8. PubMed ID: 23128385
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats.
Choi G; Hofstra JJ; Roelofs JJ; Florquin S; Bresser P; Levi M; van der Poll T; Schultz MJ
Crit Care Med; 2007 May; 35(5):1362-8. PubMed ID: 17414732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
